Hai dimenticato la password?
|
Registrati
E-mail
Password
Resta Collegato
Cerca per parole nell'archivio:
In archivio:
N° Relazioni:
478
N° Accessi Relaz.:
168938
home
|
progetto
|
chi siamo
|
servizi
|
contatti
|
note legali
III° CONGRESSO ICAR 2011- Italian Conference on AIDS and Retroviruses.... -
Palazzo Congressi e Palazzo Affari (FI)
27/03/2011 - 29/03/2011
Programma Evento
Info
Mostra tutti
|
Mostra contenuti EasyRec
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
Sabbatini F.
IMPACT OF RENAL IMPAIRMENT AND COMBINED ANTIRETROVIRAL TREATMENT ON ARTERIAL STRUCTURE AND STIFFNESS
Sagnelli C.
FACTORS INFLUENCING LIVER FIBROSIS AND NECROINFLAMMATION IN HIV/HCV COINFECTION AND HCV MONOINFECTION
Sagnelli C.
LIVER STEATOSIS IN HIV/HCV COINFECTED AND HCV-MONOINFECTED PATIENTS: AN HISTOLOGICAL COMPARISON
Saladini F.
DEVELOPMENT OF RECOMBINANT VIRUS ASSAYS FOR PHENOTYPIC EVALUATION OF THE SUSCEPTIBILITY TO INTEGRASE INHIBITORS AND HIV CORECEPTOR TROPISM
Santantonio T.
Diagnostic tools for the staging of the disease: Laboratory in the definition of the viral framework and fibrosis
Santoro M.M.
THE LOWEST X4 GENO2 PHENO-FALSE POSITIVE RATE IS ASSOCIATED WITH GREATER CD4 DEPLETION
Saracino A.
IMPACT OF MUTATIONS OUTSIDE V3 ON CORECEPTOR TROPISM PHENOTYPICALLY ASSESSED IN SUBTYPE B HIV- 1- INFECTED PATIENTS
Sarmati L.
RELIABILITY AND UTILITY OF ULTRASENSITIVE VIRAL LOAD QUANTIFICATION IN CLINICAL PRACTICE - Importance of ultrasensitive viral load quantification in clinical practice
Sarmati L.
PROVIRAL DNA: TECHNOLOGY AND CLINICAL PRACTICE AT DEBATE - Clinical importance of proviral DNA assessment
Scaramuccia D.
Schiaroli E.
LEFLUNOMIDE PROTECTS AGAINST DYSLIPIDEMIA DEVELOPMENT INDUCED BY RITONAVIR IN MICE
Scheda Relatore
Scognamiglio P.
FINAL RESULTS OF AN OUTREACH PROGRAM OF HIV RAPID TESTING AMONG MARGINALIZED PEOPLE LIVING IN ROME, ITALY
Silvestri G.
AIDS Immunology and Immunopathology
SIMIT Premio
Suligoi B.
INTRODUCTION
Surdo M.
DUAL/MIXED (BUT NOT X4) TROPIC-HIV-1 ISOLATES CAN REPLICATE IN HUMAN PRIMARY MACROPHAGES AND ARE INHIBITED BY CCR5-INHIBITORS
Svicher V.
Update on pathogenesis of HIV-hepatitis co-infection
home
|
progetto
|
chi siamo
|
servizi
|
contatti
|
note legali
Tuttocongressi ©1995 - 2026 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze | P.Iva 03755090481